ACTO Named Among Everest Group’s Top 50™ Pharmaceutical Technology Providers for 2026
Recognition underscores ACTO’s leadership in AI-powered field excellence and agentic AI purpose-built for Life Sciences TORONTO and NEW YORK, Sept. 14, 2026 /PRNewswire/ — ACTO, uniting human intelligence with empathetic AI in Life
